首页> 外文期刊>Data in Brief >Data on clinical characteristics of a heart failure patients’ cohort with reduced ejection fraction and analysis of the circulating values of five different heart failure biomarkers; high sensitivity troponin T, galectin-3, C-terminal propeptide of type I procollagen, soluble AXL and BNP
【24h】

Data on clinical characteristics of a heart failure patients’ cohort with reduced ejection fraction and analysis of the circulating values of five different heart failure biomarkers; high sensitivity troponin T, galectin-3, C-terminal propeptide of type I procollagen, soluble AXL and BNP

机译:射血分数降低的心力衰竭患者队列的临床特征数据,以及五种不同心力衰竭生物标记物的循环值分析;高敏感性肌钙蛋白T,galectin-3,I型胶原原C端前肽,可溶性AXL和BNP

获取原文
       

摘要

In this article, the full description of a heart failure with reduced ejection fraction (HF_REF) cohort of 192 patients is provided. Tables with the baseline demographic, prior history, ECG parameters, echocardiographic parameters, laboratory values and pharmacological treatment of these patients are included. Also, the quartile values of the analyzed circulating biomarkers: high sensitivity Troponin T (hs-TnT), galectin-3 (Gal-3), C-terminal propeptide of type I procollagen (CICP), soluble AXL (sAXL) and Brain Natriuretic Peptide (BNP) are given. The main demographic and clinical features of the patients’ subgroups that have hs-TnT, Gal-3, CICP or BNP above the third quartile are described. Tables with Pearson correlation analysis of the HF_REF patients’ biomarker levels are included. And Pearson correlation analysis of the HF_REF patients’ hs-TnT, Gal-3, CICP levels with patients’ biochemical parameters, blood count and inflammation parameters are also described. These data are related to the research articles (AXL receptor tyrosine kinase is increased in patients with heart failure (M. Batlle, P. Recarte-Pelz, E. Roig, M.A. Castel, M. Cardona, M. Farrero, et al., 2014) [1] and Use of serum levels of high sensitivity troponin T, galectin-3 and C-terminal propeptide of type I procollagen at long term follow-up in Heart Failure patients with reduced ejection fraction: comparison with soluble AXL and BNP (M. Batlle, B. Campos, M. Farrero, M. Cardona, B. González, M.A. Castel, et al., 2016) [2].
机译:本文提供了192名患者的射血分数降低(HF_REF)队列减少的心力衰竭的完整描述。包括具有这些患者的基线人口统计学,既往史,心电图参数,超声心动图参数,实验室值和药理学治疗的表格。同样,分析的循环生物标志物的四分位数值:高敏感性肌钙蛋白T(hs-TnT),半乳凝素3(Gal-3),I型胶原蛋白C端前肽(CICP),可溶性AXL(sAXL)和脑钠尿给出了肽(BNP)。描述了在第三四分位数以上具有hs-TnT,Gal-3,CICP或BNP的患者亚组的主要人口统计学和临床​​特征。包括具有HF_REF患者生物标志物水平的Pearson相关分析的表。还描述了HF_REF患者的hs-TnT,Gal-3,CICP水平与患者的生化参数,血球计数和炎症参数的Pearson相关分析。这些数据与研究文章有关(心力衰竭患者中AXL受体酪氨酸激酶增加(M. Batlle,P.Recarte-Pelz,E.Roig,MA Castel,M.Cardona,M.Farrero等, 2014)[1]并在长期随访中对射血分数降低的心力衰竭患者使用高敏感性肌钙蛋白T,半乳糖凝集素3和I型胶原蛋白C端前肽的血清水平:与可溶性AXL和BNP的比较( M. Batlle,B。Campos,M。Farrero,M。Cardona,B。González,MA Castel等,2016)[2]。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号